# HA Sustainable Infrastructure Capital, Inc.: financial statements, quarterly

HASI · NYSE · CIK 1561894 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hasi.md) · [Financials](/companies/hasi/financials.md) · [Filings](/companies/hasi/filings.md) · [Insiders](/companies/hasi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hasi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [89.9](/filings/0001561894-24-000109.md) | [86.6 d](/filings/0001561894-26-000007.md) | [106](/filings/0001561894-25-000062.md) | [94.5](/filings/0001561894-25-000107.md) | [82.0](/filings/0001561894-25-000123.md) | [101 d](/filings/0001561894-26-000007.md) | [96.9](/filings/0001561894-26-000074.md) | [85.7](/filings/0001561894-26-000136.md) | [103](/filings/0001561894-25-000123.md) | [115 d](/filings/0001561894-26-000007.md) | [124](/filings/0001561894-26-000074.md) | [121](/filings/0001561894-26-000136.md) |
| Interest expense | $m | [43.3](/filings/0001561894-23-000114.md) | [50.6 d](/filings/0001561894-26-000007.md) | [61.9](/filings/0001561894-25-000062.md) | [59.5](/filings/0001561894-25-000107.md) | [59.4](/filings/0001561894-25-000123.md) | [61.6 d](/filings/0001561894-26-000007.md) | [64.7](/filings/0001561894-26-000074.md) | [79.7](/filings/0001561894-26-000136.md) | [71.5](/filings/0001561894-25-000123.md) | [76.5 d](/filings/0001561894-26-000007.md) | [99.3](/filings/0001561894-26-000074.md) | [87.5](/filings/0001561894-26-000136.md) |
| Income tax | $m | [(5.1)](/filings/0001561894-24-000109.md) | [36.9 d](/filings/0001561894-26-000007.md) | [46.2](/filings/0001561894-25-000062.md) | [10.3](/filings/0001561894-25-000107.md) | [(7.1)](/filings/0001561894-25-000123.md) | [20.8 d](/filings/0001561894-26-000007.md) | [23.9](/filings/0001561894-26-000074.md) | [38.2](/filings/0001561894-26-000136.md) | [34.5](/filings/0001561894-25-000123.md) | [(11.3) d](/filings/0001561894-26-000007.md) | [(30.8)](/filings/0001561894-26-000074.md) | [57.0](/filings/0001561894-26-000136.md) |
| Net income | $m | [21.4](/filings/0001561894-24-000109.md) | [89.8 d](/filings/0001561894-26-000007.md) | [123](/filings/0001561894-25-000062.md) | [26.5](/filings/0001561894-25-000107.md) | [(19.6)](/filings/0001561894-25-000123.md) | [70.1 d](/filings/0001561894-26-000007.md) | [56.6](/filings/0001561894-26-000074.md) | [98.4](/filings/0001561894-26-000136.md) | [83.3](/filings/0001561894-25-000123.md) | [(53.8) d](/filings/0001561894-26-000007.md) | [(72.0)](/filings/0001561894-26-000074.md) | [129](/filings/0001561894-26-000136.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001561894-24-000109.md) | not reported | [0.98](/filings/0001561894-25-000062.md) | [0.23](/filings/0001561894-25-000107.md) | [(0.17)](/filings/0001561894-25-000123.md) | not reported | [0.44](/filings/0001561894-26-000074.md) | [0.74](/filings/0001561894-26-000136.md) | [0.61](/filings/0001561894-25-000123.md) | not reported | [(0.57)](/filings/0001561894-26-000074.md) | [0.92](/filings/0001561894-26-000136.md) |
| Basic EPS | $ per share | [0.20](/filings/0001561894-24-000109.md) | not reported | [1.08](/filings/0001561894-25-000062.md) | [0.23](/filings/0001561894-25-000107.md) | [(0.17)](/filings/0001561894-25-000123.md) | not reported | [0.47](/filings/0001561894-26-000074.md) | [0.80](/filings/0001561894-26-000136.md) | [0.66](/filings/0001561894-25-000123.md) | not reported | [(0.57)](/filings/0001561894-26-000074.md) | [1.00](/filings/0001561894-26-000136.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [156](/filings/0001561894-23-000114.md) | [62.6](/filings/0001561894-25-000007.md) | [61.4](/filings/0001561894-24-000061.md) | [146](/filings/0001561894-24-000097.md) | [44.1](/filings/0001561894-24-000109.md) | [130](/filings/0001561894-26-000007.md) | [67.4](/filings/0001561894-25-000062.md) | [86.5](/filings/0001561894-25-000107.md) | [302](/filings/0001561894-25-000123.md) | [110](/filings/0001561894-26-000136.md) | [124](/filings/0001561894-26-000074.md) | [250](/filings/0001561894-26-000136.md) |
| Total assets | $m | [5,908](/filings/0001561894-23-000114.md) | [6,552](/filings/0001561894-25-000007.md) | [6,728](/filings/0001561894-24-000061.md) | [6,659](/filings/0001561894-24-000097.md) | [6,673](/filings/0001561894-24-000109.md) | [7,080](/filings/0001561894-26-000007.md) | [7,476](/filings/0001561894-25-000062.md) | [7,596](/filings/0001561894-25-000107.md) | [8,204](/filings/0001561894-25-000123.md) | [8,188](/filings/0001561894-26-000136.md) | [8,202](/filings/0001561894-26-000074.md) | [8,941](/filings/0001561894-26-000136.md) |
| Total liabilities | $m | [3,808](/filings/0001561894-23-000114.md) | [4,411](/filings/0001561894-25-000007.md) | [4,455](/filings/0001561894-24-000061.md) | [4,336](/filings/0001561894-24-000097.md) | [4,349](/filings/0001561894-24-000109.md) | [4,675](/filings/0001561894-26-000007.md) | [5,005](/filings/0001561894-25-000062.md) | [5,008](/filings/0001561894-25-000107.md) | [5,518](/filings/0001561894-25-000123.md) | [5,530](/filings/0001561894-26-000136.md) | [5,668](/filings/0001561894-26-000074.md) | [6,291](/filings/0001561894-26-000136.md) |
| Long-term debt | $m | [168](/filings/0001561894-23-000114.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [50.0](/filings/0001561894-23-000114.md) | [30.2](/filings/0001561894-25-000007.md) | [65.3](/filings/0001561894-24-000061.md) | [110](/filings/0001561894-24-000097.md) | [18.3](/filings/0001561894-24-000109.md) | [100](/filings/0001561894-26-000007.md) | [430](/filings/0001561894-25-000062.md) | [356](/filings/0001561894-25-000107.md) | [670](/filings/0001561894-25-000123.md) | [225](/filings/0001561894-26-000136.md) | [0.1](/filings/0001561894-26-000074.md) | [0.1](/filings/0001561894-26-000136.md) |
| Shareholders' equity | $m | [2,100](/filings/0001561894-24-000109.md) | [2,142](/filings/0001561894-26-000007.md) | [2,273](/filings/0001561894-25-000107.md) | [2,323](/filings/0001561894-25-000123.md) | [2,323](/filings/0001561894-25-000123.md) | [2,405](/filings/0001561894-26-000136.md) | [2,471](/filings/0001561894-26-000136.md) | [2,589](/filings/0001561894-26-000136.md) | [2,686](/filings/0001561894-25-000123.md) | [2,658](/filings/0001561894-26-000136.md) | [2,535](/filings/0001561894-26-000136.md) | [2,650](/filings/0001561894-26-000136.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.6 d](/filings/0001561894-24-000109.md) | [7.3 d](/filings/0001561894-26-000007.md) | [20.9](/filings/0001561894-25-000062.md) | [(24.8) d](/filings/0001561894-25-000107.md) | [21.9 d](/filings/0001561894-25-000123.md) | [(12.2) d](/filings/0001561894-26-000007.md) | [(37.1)](/filings/0001561894-26-000074.md) | [79.6 d](/filings/0001561894-26-000136.md) | [(122) d](/filings/0001561894-25-000123.md) | [247 d](/filings/0001561894-26-000007.md) | [15.6](/filings/0001561894-26-000074.md) | [68.0 d](/filings/0001561894-26-000136.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [43.0 d](/filings/0001561894-24-000109.md) | [44.7 d](/filings/0001561894-26-000007.md) | [45.1](/filings/0001561894-25-000062.md) | [48.2 d](/filings/0001561894-25-000107.md) | [48.9 d](/filings/0001561894-25-000123.md) | [50.1 d](/filings/0001561894-26-000007.md) | [50.4](/filings/0001561894-26-000074.md) | [52.0 d](/filings/0001561894-26-000136.md) | [53.2 d](/filings/0001561894-25-000123.md) | [54.1 d](/filings/0001561894-26-000007.md) | [56.8](/filings/0001561894-26-000074.md) | [55.8 d](/filings/0001561894-26-000136.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [90.8](/filings/0001561894-23-000114.md) | [94.1](/filings/0001561894-24-000061.md) | [100.0](/filings/0001561894-24-000097.md) | [109](/filings/0001561894-24-000109.md) | [131](/filings/0001561894-25-000062.md) | [114](/filings/0001561894-25-000107.md) | [117](/filings/0001561894-25-000123.md) | [138](/filings/0001561894-26-000074.md) | [138](/filings/0001561894-26-000136.md) | [140](/filings/0001561894-25-000123.md) | [128](/filings/0001561894-26-000074.md) | [143](/filings/0001561894-26-000136.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 128,495,790 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001561894-26-000136.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.